ziftomenib 200 MG Oral Capsule [Komzifti]

Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.

Start free with Eleplan

Clinical drug

ziftomenib 200 MG Oral Capsule [Komzifti]

200 MG · Oral Capsule · oral

A form of ziftomenib →

ziftomenib 200 MG Oral Capsule [Komzifti]. Strength, form, class, interactions & more.

ziftomenib 200 MG Oral Capsule [Komzifti]

Active ingredient

Classification

Menin Inhibitor

Drug interactions

Ziftomenib has several significant drug interactions that may affect its efficacy and safety.

  • majorstrong or moderate CYP3A4 inhibitors — increased risk of adverse reactions such as QT prolongation
  • majorstrong or moderate CYP3A4 inducers — decreased efficacy of ziftomenib
  • majorproton pump inhibitors — decreased efficacy of ziftomenib
  • majorH2 receptor antagonists and antacids — decreased efficacy of ziftomenib
  • majordrugs that prolong the QTc interval — increased risk of QTc interval prolongation and associated serious arrhythmias

Source: RxNorm + openFDA + RxClass + FAERS · 2026

Look up another medication

Powered by Eleplan

A drug lookup is just the start. Eleplan keeps the whole care plan in one place.

Medications, diagnoses, documents, appointments, and the whole care team — organized and always in sync, with Ellie, your AI care assistant, on top of it. Free to start.